Project Details
Description
Induced NK Cell Therapeutics Manufacturing - preclinical Phase 1 & 2
| Status | Finished |
|---|---|
| Effective start/end date | 6/19/17 → 12/31/18 |
Funding
- FATE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.